No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009

• Main Authors: Salaheddin M. Mahmud, Paul Van Caeseele, Gregory Hammond, Carol Kurbis, Tim Hilderman, Lawrence Elliott
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2012-05-01
• Series: Emerging Infectious Diseases
• Subjects: epidemiology; pandemic influenza A (H1N1), trivalent influenza vaccines, case-control study, influenza, Canada; pandemic (H1N1) 2009; pandemic (H1N1) 2009 virus; pandemic A(H1N1)2009 virus; pandemic influenza A (H1N1) 2009
• Online Access: https://wwwnc.cdc.gov/eid/article/18/5/11-1596_article

We conducted a population-based study in Manitoba, Canada, to investigate whether use of inactivated trivalent influenza vaccine (TIV) during the 2008–09 influenza season was associated with subsequent infection with influenza A(H1N1)pdm09 virus during the first wave of the 2009 pandemic. Data were obtained from a provincewide population-based immunization registry and laboratory-based influenza surveillance system. The test-negative case–control study included 831 case-patients with confirmed influenza A(H1N1)pdm09 virus infection and 2,479 controls, participants with test results negative for influenza A and B viruses. For the association of TIV receipt with influenza A(H1N1)pdm09 virus infection, the fully adjusted odds ratio was 1.0 (95% CI 0.7–1.4). Among case-patients, receipt of 2008–09 TIV was associated with a statistically nonsignificant 49% reduction in risk for hospitalization. In agreement with study findings outside Canada, our study in Manitoba indicates that the 2008–09 TIV neither increased nor decreased the risk for infection with influenza A(H1N1)pdm09 virus.